ライフサイエンスコーパス: than in those

コーパス検索結果 (right1)

通し番号をクリックするとPubMedの該当ページを表示します

1 ounger than 5 years (30% [95% CI 15-42], I(2)=0%) was lower than in those 5 years or older (64% [58-70], I(2)=0%; p<0.000

2 individuals younger than 15 years old was typically higher than in those aged 15 years or older.

3 higher in children aged 0-4 years (43.6%, 95% CI 36.8-50.6) than in those aged 5-14 years (14.9%, 11.5-19.1).

4 given bictegravir, emtricitabine, and tenofovir alafenamide than in those given dolutegravir, abacavir, and lamivudine (1

5 rVSVG-ZEBOV-GP group (79.5%) remained significantly greater than in those in the placebo group (6.8%, P<0.001 for both co

6 icipants in the long-acting cabotegravir group (n=75 [80%]) than in those in the placebo group (n=10 [48%]; p=0.0049), mo

7 risk bacteremia patients without (18)F-FDG PET/CT performed than in those in whom (18)F-FDG PET/CT was performed (32.7% v

8 ls was higher in skin and intestinal lesions of BD patients than in those of HCs.

9 in the murine oral cavities of infected gp91(phox) KO mice than in those of iNOS KO and C57BL/6 mice.

10 4) and survivors of acute symptomatic CSE (13.3%, 3.7-37.9) than in those of remote symptomatic CSE (45.5%, 21.3-72.0) an

11 urons in the trigeminal ganglia of latently infected calves than in those of uninfected calves.

12 onths was lower in participants continuing lisdexamfetamine than in those randomized to placebo.

13 s is significantly lower in patients receiving teriparatide than in those receiving risedronate.

14 rsus 3.3 [2.1-6.1]; P=0.01) and in patients with vasculitis than in those referred for other indications.

15 her in patients screened with DBT plus synthetic 2D imaging than in those screened with FFDM among women classified as ha

16 ed the coaching-based WHO Safe Childbirth Checklist program than in those that did not, but maternal and perinatal mortal

17 aker in mice that initially presented with persistent warts than in those that spontaneously cleared their infection.

18 more frequent in patients treated for visceral involvement than in those treated for skin involvement (n = 12 of 25 [48%

19 greater in G6PD-deficient patients who received primaquine than in those who did not and one patient who received primaq

20 f cancer was higher in patients who had extensive screening than in those who had more limited screening initially (odds

21 patients who had infectious enteritis in the past 12 months than in those who had not (95% CI, 3.1-5.7); risk of IBS was

22 self-harm during the adolescent phase of the study (n=135) than in those who had not (n=1536): for social disadvantage o

23 ee survival was longer in patients who received ipatasertib than in those who received placebo.

24 ical toxicity was more common in patients treated with ASCT than in those who received WBRT.

25 ion in infancy was 2.2 mm Hg (95% CI: 0.3, 4.2 mm Hg) lower than in those who were unsupplemented (P = 0.026).

26 protective genotypes was observed in patients without (80%) than in those with (20%) ACLF.

27 3 duplication was more prevalent in this Chinese population than in those with European ancestry.

28 isk of reoperation in patients with DCIS was 3 times higher than in those with IBC.

29 y higher in countries with highly restrictive abortion laws than in those with less restrictive laws.

30 -free survival was longer in patients with high GARD values than in those with low GARD values (hazard ratio 2.11, 95% 1.

31 LD and is significantly more prevalent in patients with IPF than in those with other fibrosing ILDs, and thus, computed t

32 e was lower in patients with possible LRTI (12 of 45 [27%]) than in those with proven/probable LRTI (29 of 42 [69%]).

33 r in individuals with previously diagnosed diabetes (18.9%) than in those with screen-detected diabetes (6.7%) or no diab

34 reduced hand grip strength (HR: 1.53; 95% CI: 10.07, 2.17) than in those with stable weight and grip strength, with the

35 cipants with two or more respiratory exacerbations per year than in those with zero exacerbations (4194+/-878 vs. 2458+/-

36 her in patients with clonal haemopoiesis (29%, 95% CI 8-53) than in those without (0%, 0-0; p=0.0009).

37 er in patients with clonal haemopoiesis (30%, 95% CI 16-51) than in those without (7%, 2-21; p=0.016).

38 nts with congestive heart failure or ischemic heart disease than in those without (P = 0.021 for interaction term).

39 SM), increased with age, and was higher in people with AIDS than in those without AIDS (ie, HIV only; adjusted incidence

40 >4 mm and BOP was significantly higher in patients with AM than in those without AM (31.8 +/- 12.6% vs. 20.8 +/- 14.7%;

41 > 4 mm and BOP was significantly higher in patients with AM than in those without AM (31.8% +/- 12.6% versus 20.8% +/- 14

42 io was higher in patients with moderate or severe steatosis than in those without any steatosis (P < 0.001).

43 /arterial duct diameter ratio was lower in fetuses with CoA than in those without CoA (P<0.001).

44 uspid valve diameter z score was higher in fetuses with CoA than in those without CoA (P=0.01).

45 or tuberculosis (especially without antiretroviral therapy) than in those without HIV.

46 on 1) was significantly higher in patients with IPF (28.5%) than in those without IPF (8.3%, P < .001).

47 STDR prevalence was higher in patients with OSA than in those without OSA (42.9% vs. 24.1%; P = 0.004).

48 ividuals with a history of TB disease less than 6 years ago than in those without previous TB.

49 rtality was 10-fold higher in SOT patients with nocardiosis than in those without.

50 .16) in those pupils with caries in their primary dentition than in those without.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。